Amphion Innovations Share Discussion Threads

[letmepass] 04/10/2017 10:11

Booom.. next few days will see a massive increase

[dave4545] 04/10/2017 10:11

oops just falia left now.

I wonder if they all live in the same house, where is myah ?

Stake in mtfb worth around 18-20 million, liabilities 31 million in recent accounts.

Kromek gone no more to sell, stakes in start ups are the key.

[debbie_does_dallas_twice] 04/10/2017 10:10

Look at the facts and not dagenham dave's bitter spiteful deramps..
The shares now have a circa value of 5p with mtfb at 50p

Financial Results (note how a 4p recovery on mtfb changed the nav by 1.4p.) this was when the price was 31p).

-- Net Asset Value ("NAV") per share was -1p (US -$0.02 cents)* at Period-end from -2.4p (US -$0.03 cents) as at year end. This increase was due almost entirely to the movement in value of the Motif Bio plc share price

Highlights

Amphion

[letmepass] 04/10/2017 10:09

5p coming today

[longshanks] 04/10/2017 10:08

This is quite a good stock to hold as a way of leveraging any price increase in MTFB. But the liabilities are massive so one does need to mind the fact that shareholder returns are less certain. I bought a small stake today for that reason. I will sell if we see 4p

[dave4545] 04/10/2017 10:08

bullet ant

Strange you keep forgetting to mention their debt/liabilities of 31 million ??

Any reason why ?

[debbie_does_dallas_twice] 04/10/2017 10:07

Dave spreading outright lies - filtered!!!
Check the results the nav when mtfb was 26p was -1p it is now nearly 5p at MTFB @50p

[bullet ant] 04/10/2017 10:06

I would not discount 4.0p today.


Their holding in Motif multiple their mcap.


Motif goes 100p, as in phase and FDA approval motif till be worth many millions

[dave4545] 04/10/2017 10:06

Time to log in and out with all your multiple names as well bullet ant ?

[dave4545] 04/10/2017 10:05

Here comes the pump and dump squad, just need falia now.

Remember if AMP sold all their MTFB at 50p it would still not clear their liabilities.

[debbie_does_dallas_twice] 04/10/2017 10:05

NAV is now 4.87p.... and rising FAST!!!

[shirley83] 04/10/2017 10:04

5p on way today

[dave4545] 04/10/2017 10:02

Total liabilities 31,079,524

Just keeping it correct. I doubt the pump and dumpers will

[bullet ant] 04/10/2017 10:01

AMP mcap 4.8m and their holding in Motif is worth £20M??

[bullet ant] 04/10/2017 10:00

Do they have £19m worth of shares in motif?

[bullet ant] 04/10/2017 09:58

Motif Bio PLC Holding(s) in Company

25/09/2017 7:01am
UK Regulatory (RNS & others)

Amphion (LSE:AMP)
Historical Stock Chart
1 Month : From Sep 2017 to Oct 2017

Click Here for more Amphion Charts.
TIDMMTFB TIDMAMP

RNS Number : 6347R

Motif Bio PLC

25 September 2017

25 September 2017

Motif Bio plc

("Motif" or the "Group")

Holding(s) in the Company

Motif Bio plc (AIM: MTFB), the clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that it was informed on 22 September 2017 by Amphion Innovations plc ("Amphion") that a total of 4,390,000 ordinary shares in the Company had been sold in respect of a partial repayment of a loan facility, which is secured by Motif Bio shares held by Amphion. Amphion is now the beneficial owner of 37,150,645 ordinary shares in the Company, representing 14.1% of the issued share capital.

Following this sale, Amphion has agreed an amendment to the loan facility with its lender such that no further Motif Bio shares will be sold before 15 January 2018. The full details of this amendment may be found in the RNS announcement released by Amphion today.

The TR-1 disclosure is set out below.

[bullet ant] 04/10/2017 09:53

This should up to 3.5p-4.0p by the end of the day

[bullet ant] 04/10/2017 09:52

That was before mtfb price up nearly 40% today





Financial Results

-- Net Asset Value ("NAV") per share was -1p (US -$0.02 cents)* at Period-end from -2.4p (US -$0.03 cents) as at year end. This increase was due almost entirely to the movement in value of the Motif Bio plc share price

Highlights

Amphion

-- Sold the Company's remaining holding of Kromek Group plc
-- Richard Morgan and Robert Bertoldi, Directors of the Company, entered into a Deed of Postponement where they agreed to postpone the repayment of the amounts owed to them, which total US $4.3 million, until all other debts of the Company are repaid

Motif Bio

-- In January, Motif Bio completed treatment of patients in its Phase III trial (REVIVE-1) for its product candidate iclaprim

-- In April, Motif Bio released data readout from REVIVE-1, showing iclaprim to be well tolerated and met the non-inferiority margin mandated by the FDA

Polarean

[tomboyb] 04/10/2017 09:52

Yeah -

I think there is a lot of work to do here hence the current share price -

So it is a small punt only from me -

[bullet ant] 04/10/2017 09:48

Same here tomboy


Their Holdings in MTFT has gone more than multiple of the mcap here.

[tomboyb] 04/10/2017 09:47

picked up a few today -

very good rns from mftb -

[2pablo] 12/9/2017 08:33

MTFB - a long way to go to get back to previous highs but certainly on it's way. Lot of skin in the game, lifetime's work involved in AMP to just see it fail, hopefully.

[small crow] 12/9/2017 08:17

If MTFB continues like this, AMP may just have dodged the debt ] bullet. In which case it's a cheap way into MTFB at these levels.